Sofregen is a manufacturer of a biomedical silk protein intended to facilitate soft-tissue bulking and regeneration for a range of procedures in medical aesthetics and other medical applications. Sofregen’s Silk Voice®, a silk protein injectable implant & catheter, was cleared by the U.S. FDA in 2019 for vocal fold medialization and vocal fold insufficiency.
Looking for a particular Sofregen Inc. employee's phone or email?
The Sofregen Inc. annual revenue was $6 million in 2026.
Sofregen Inc. is based in Framingham, Massachusetts.
The NAICS codes for Sofregen Inc. are [541, 541713, 54, 5417, 54171].
The SIC codes for Sofregen Inc. are [87, 873].